Detalhe da pesquisa
1.
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.
Breast Cancer Res
; 25(1): 134, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924153
2.
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
Int J Cancer
; 152(2): 320-330, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054443
3.
Plasma Cell-Free DNA in Uterine Cervical Cancer: Therapeutic Monitoring and Prognostic Values after Radical Radiotherapy.
Cancer Res Treat
; 55(2): 659-670, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510654
4.
Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth.
Front Oncol
; 12: 841398, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402263